Cellectar Biosciences Inc. (NASDAQ: CLRB)
$2.78
+0.2200 ( +8.59% ) 345.8K
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
Market Data
Open
$2.78
Previous close
$2.56
Volume
345.8K
Market cap
$100.02M
Day range
$2.56 - $2.79
52 week range
$1.56 - $4.45
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Nov 02, 2023 |
8-k | 8K-related | 13 | Oct 27, 2023 |
def | Proxies and info statements | 6 | Oct 02, 2023 |
pre | Proxies and info statements | 5 | Sep 22, 2023 |
8-k | 8K-related | 18 | Sep 08, 2023 |
8-k | 8K-related | 12 | Aug 21, 2023 |
10-q | Quarterly Reports | 43 | Aug 14, 2023 |
8-k | 8K-related | 13 | Aug 14, 2023 |